The Perfect Cure for Hepatitis C? - Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
March 5th, 2013 - News
February 25th, 2013 - News
February 20th, 2013 - News
February 15th, 2013 - News
February 13th, 2013 - News
February 11th, 2013 - News
Returns since its inception in May 2014 (through November 14th, 2024)